Your browser doesn't support javascript.
loading
Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi-institutional collaborative.
Winer, Leah K; Akumuo, Rita; Fredette, Jordan D; Deng, Mengying; Hasler, Jill S; Greco, Stephanie H; von Mehren, Margaret; Bartholomew, Alex J; Blazer, Dan G; Gabrielova, Lucie; Adamkova, Dagmar; Bernard-Bedard, Ericka; Nessim, Carolyn; Kollár, Attila; Olariu, Radu; Cencelj-Arnez, Romi; Hompes, Daphne; Ford, Samuel J; Cardona, Kenneth; Sato, Kenji; Iwata, Shintaro; Farma, Jeffrey M; Villano, Anthony M.
Afiliación
  • Winer LK; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Akumuo R; Department of General Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.
  • Fredette JD; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Deng M; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Hasler JS; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Greco SH; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • von Mehren M; Division of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Bartholomew AJ; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.
  • Blazer DG; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.
  • Gabrielova L; Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic.
  • Adamkova D; Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic.
  • Bernard-Bedard E; Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada.
  • Nessim C; Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada.
  • Kollár A; Department of Medical Oncology, Inselspital, Bern University Hospital, Univesity of Bern, Bern, Switzerland.
  • Olariu R; Department of Plastic and Hand Surgery, Inselspital, Bern University Hospital, Freiburgstrasse, Switzerland.
  • Cencelj-Arnez R; Division of Surgery, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Hompes D; Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Ford SJ; Sarcoma Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • Cardona K; Division of Surgical Oncology, Emory University Hospital, Atlanta, Georgia, USA.
  • Sato K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Iwata S; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Farma JM; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Villano AM; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Cancer ; 2024 Jul 10.
Article en En | MEDLINE | ID: mdl-38985726
ABSTRACT

BACKGROUND:

Dermatofibrosarcoma protuberans (DFSP) is a cutaneous sarcoma with an infiltrative growth pattern that makes it challenging to clear margins. High quality data regarding DFSP natural history, management, and outcomes are limited.

METHODS:

Data were retrospectively collected for adult DFSP patients who underwent resection at 10 institutions in eight countries. Demographics, tumor characteristics, treatment strategies, and outcomes were analyzed.

RESULTS:

Analysis included 347 patients consisting of young (median, 42 years), White (76.2%), males (54.2%) with truncal lesions (57.3%). The majority (76.8%) were symptomatic at presentation. Preoperative imaging was used in 55.9% of cases. Diagnosis was established with excisional biopsy in 50.9% versus incisional biopsy in 25.0% of cases. Despite planned margins of >1.0 cm in 67.4% of cases, only 69.0% of patients achieved R0 resection. Twenty-two percent of patients underwent at least one re-excision. R0 resection was achieved at a second procedure in 80.2% and a third procedure in 86.2%. Ultimately, R0 resection was feasible in 89.5% of all patients. Fibrosarcomatous transformation (FST) was observed in 12.6%. In total, 6.6% (N = 23) recurred (17 local, six distant). Of the six distant recurrences, 50.0% had FST. With a median follow-up of 47.0 months, disease-specific survival rate was 98.8%. In multivariable analysis, R0 margins at index resection were associated with wider circumferential margins and non-FST histology.

CONCLUSIONS:

In this international, multicenter collaborative, DFSP practice patterns were heterogeneous but achieved favorable recurrence rates and survival. Multiple excisions to clear margins remain commonplace and can inform future efforts to optimize margin selection.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos